ABSTRACT
OBJECTIVE: The purpose of this study was to evaluate the angiotensin-converting enzyme gene polymorphism in pregnant women with and without preeclampsia. STUDY DESIGN: Preeclampsia was defined as hypertension and pathologic proteinuria in pregnant women after gestational week 20. Genomic DNA was isolated from leukocytes. The insertion-deletion polymorphism in intron 16 of the angiotensin-converting enzyme gene was detected in DNA samples with the use of the polymerase chain reaction. Chi-squared and Student t tests were used for statistical analysis. RESULTS: In preeclampsia (n=51 women) angiotensin-converting enzyme genotypes were deletion-D (DD) in 16 women (31%), insertion-I (II) in 12 women (24%), and insertion-deletion in 23 women (45%); in the control group (n=71), the angiotensin-converting enzyme genotypes were DD in 21 women (30%), II in 17 women (24%), and insertion-deletion in 33 women (46%). Angiotensin-converting enzyme genotype distribution and allelic frequencies were not different between groups. CONCLUSION: No difference in the angiotensin-converting enzyme genotype distribution was found between preeclampsia and normal pregnancy. The results showed no association between angiotensin-converting enzyme polymorphism and the development of preeclampsia.
Subject(s)
Peptidyl-Dipeptidase A/genetics , Polymorphism, Genetic/genetics , Pre-Eclampsia/genetics , Alleles , Female , Gene Deletion , Gene Frequency , Gestational Age , Humans , Mutagenesis, Insertional , Polymerase Chain Reaction , Pre-Eclampsia/enzymology , PregnancyABSTRACT
OBJECTIVE: This study was undertaken to evaluate erythrocyte membrane transport of L-arginine in pregnancy and immediately postpartum. STUDY DESIGN: The study comprised 103 women with normal pregnancy, initially evaluated at the second trimester (II), followed into the third trimester (III), and immediately postpartum (PP). Total erythrocyte L-arginine uptake was measured with (14)C-L-arginine, at 37 degrees C, for 3 minutes. The maximal transport capacity (V(max)) and half-saturation constant (K(m)) were obtained with the use of Michaelis-Menten kinetics. Results are expressed as mean+/-SD. Analysis of variance, followed by Tukey test, was used in statistical analysis (alpha< or =.05). RESULTS: V(max) (micromol/L cells per hour) progressively increased at each consecutive time period: 779+/-283, 946+/-289, and 1349+/-390, at II, III, and PP, respectively (P<.001). Similarly, K(m) (micromol/L) values increased from 56+/-20 at time II, to 62+/-18 at time III, and 69+/-24 at PP (P<.001). CONCLUSION: Total erythrocyte L-arginine uptake (V(max) and K(m)) increases progressively along normal pregnancy, with a further increase immediately postpartum.
Subject(s)
Arginine/metabolism , Erythrocytes/metabolism , Postpartum Period/metabolism , Pregnancy/metabolism , Adult , Biological Transport , Female , Humans , Pregnancy Trimester, First/metabolism , Pregnancy Trimester, Second/metabolism , Pregnancy Trimester, Third/metabolismABSTRACT
Hemoglobinúria Paroxística Noturna (HPN) é uma doença resultante da alteração clonal da célula tronco da medula óssea, que se manifesta por episódios de hemólise intravascular, seguida de hemoglobinúria. A gestação é relatada como fator desencadeante dos episódios hemolíticos. Relata-se um caso de paciente branca, 35 anos, portadora de HPN há 11 anos que, no decorrer da terceira gestação, necessitou realizar repetidas transfusões de hemácias lavadas. Cêrca de um mês após o parto retornou à emergência do hospital, em estado toxêmico. Transferida para a UTI, apresentou acidente vascular encefálico, evoluindo para óbito
